This video explains 10 early signs and symptoms of diabetes that often go unnoticed. These include increased thirst, frequent bathroom breaks, recurrent infections, unexplained weight changes, and blurry…
This video dives into Pompe Disease, also known as Glycogen Storage Disease Type 2. The host explains the key components of this disease, where the body cannot break…
With a multitude of glucose meters on the market, it can sometimes be difficult for endocrinologists to maintain the inventory of software and cables necessary to access all…
When a fetus is exposed to high blood glucose because of maternal diabetes, this can have long-lasting effects on development. A new study examined whether exposure to maternal…
Carolyn Gershenson, RN, MSM, MPH, CDE, Long Island Diabetes and Endocrinology and Babylon Medical Practice, talks about the general problems practitioners have when treating complicated patients with type…
Carolyn Gershenson, RN, MSM, MPH, CDE, Long Island Diabetes and Endocrinology and Babylon Medical Practice describes what makes an effective diabetes assisted-care practice in the primary care setting.…
Alan M. Jacobson, MD, Chief Research Officer, Winthrop-University Hospital, offers tips for healthcare providers treating stress, depression or cognitive dysfunction in patients with diabetes. Jacobson suggests that a…
Alan M. Jacobson, MD, Chief Research Officer, Winthrop-University Hospital, discusses the impact of stress, depression and cognitive dysfunction in patients with diabetes. Jacobson defines stress as a general…
During the 1980s, the Diabetes Control & Complications Trial (DCCT) began, seeking to determine whether intensive blood sugar control would help reduce long-term complications such as vision loss,…
Xavier Pi-Sunyer, MD, MPH and Steven Edelman, MD discuss the differences in A1C reduction when using GLP-1 receptor agonists versus DPP-4 inhibitors. GLP-1 receptor agonists have a larger reduction in A1C…
Xavier Pi-Sunyer, MD, MPH describes how physicians can make the decision between whether to prescribe an injectable GLP-1 agonist treatment or an oral DPP-4 inhibitor when seeking to lower…
Xavier Pi-Sunyer, MD, MPH, discusses incretin therapy, a treatment which increases insulin secretion in type 2 diabetes patients. According to Pi-Sunyer, GLP-1 can be raised in the blood…
